Showing 1 - 6 results of 6 for search 'Qingwei Zhang', query time: 0.05s Refine Results
  1. 1
    Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors

    Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors by Yilei Huang, Han Zhang, Xinyan Peng, Qingwei Zhang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor

    An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor by Mengfei Wang, Niubing Sun, Qiushi Chen, Qingwei Zhang

    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold

    Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold by Qingwei Zhang, Guili Xu, Ya Bao, Minru Jiao, Jianqi Li

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold

    Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold by Qingwei Zhang, Guili Xu, Ya Bao, Minru Jiao, Jianqi Li

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    The factors of job crafting in emergency nurses: regression models versus qualitative comparative analysis

    The factors of job crafting in emergency nurses: regression models versus qualitative comparative analysis by Yu Wang, Qiaofang Yang, Luwen Wang, Qingwei Zhang, Yingli Li

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Design, synthesis, and biological evaluation of 2,4-dimorpholinopyrimidine-5-carbonitrile derivatives as orally bioavailable PI3K inhibitors

    Design, synthesis, and biological evaluation of 2,4-dimorpholinopyrimidine-5-carbonitrile derivatives as orally bioavailable PI3K inhibitors by Daowei Huang, Daowei Huang, Daowei Huang, Jixia Yang, Qingwei Zhang, Xiaolei Zhou, Yanbo Wang, Zhenhua Shang, Zhenhua Shang, Zhenhua Shang, Jianqi Li, Baoyin Zhang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: